Celsite Brachial Venous Port
510(k) K945752
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK945752 | Date31 May 1995 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Full name
- Celsite(Tm) Brachial Venous Port
- 510(k) Number
- FDA Product Code
- LJT
- Device Class
- Class II
- Regulation
- 21 CFR Part 880.5965
- Advisory Committee
- General Hospital
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 19 Sep 2026
The Celsite Brachial Venous Port is a subcutaneous, implanted, intravascular infusion port and catheter. It consists of a reservoir implanted beneath the skin that connects to a catheter for long-term intravenous access, facilitating reliable administration of fluids, medications, or nutrients directly into the bloodstream.
This device is intended for use in hospital settings and is supplied sterile for single-use implantation. It is classified as a Class 2 medical device under the FDA’s General Hospital category (product code LJT) and has received FDA 510(k) clearance as substantially equivalent to a predicate device. The port is designed for MRI safety compliance and is available in specific sizes as referenced in the regulatory submission.
Other devices from B. Braun of America, Inc.
Questions
AI-generated answers, 19 Sep 2026
What types of medical settings is the Celsite Brachial Venous Port intended for, and how is it typically used?
The Celsite Brachial Venous Port is designed specifically for use in hospital settings and is intended for long-term intravenous access. It is implanted beneath the skin and connects to a catheter, allowing reliable administration of fluids, medications, or nutrients directly into the bloodstream. This makes it ideal for patients requiring frequent or prolonged intravenous therapy, such as chemotherapy, antibiotics, or parenteral nutrition.
Is the Celsite Brachial Venous Port single-use or reusable, and what does that mean for its handling?
The Celsite Brachial Venous Port is sterile and intended for single-use implantation only. This means it should not be reused after initial implantation, as reuse could compromise sterility and patient safety. Proper sterile techniques must be followed during implantation and subsequent access to minimize infection risk.
Does the Celsite Brachial Venous Port come in different sizes, and if so, how might that affect its selection?
While the exact sizes are not detailed in the provided data, the Celsite Brachial Venous Port is available in specific sizes as referenced in the regulatory submission. Size selection is typically based on patient anatomy, catheter length requirements, and clinical needs to ensure proper placement and functionality. Consulting the manufacturer’s sizing guidelines or a healthcare professional is recommended to choose the appropriate model.
Can the Celsite Brachial Venous Port be used safely in MRI procedures, and what considerations should be taken?
Yes, the Celsite Brachial Venous Port is designed for MRI safety compliance, meaning it can be used in MRI procedures without posing significant risks. However, it is critical to follow MRI facility protocols and ensure the port is compatible with the specific MRI machine settings to avoid potential heating or displacement. Always verify with the MRI technician before imaging.
How should the Celsite Brachial Venous Port be stored before implantation, and what are the key storage requirements?
The Celsite Brachial Venous Port is supplied sterile, so it must be stored in its original, unopened packaging to maintain sterility until use. Storage should follow the manufacturer’s instructions, typically in a clean, dry environment away from direct sunlight or extreme temperatures. Avoid contamination or exposure to moisture, as this could compromise the device’s integrity before implantation.